glutamic acid has been researched along with latrepirdine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, SP; Anilkumar, U; Baumann, B; Bernas, T; Düssmann, H; Huber, HJ; Jordán, J; Kilbride, SM; Prehn, JH; Weisová, P | 1 |
| Kuo, JR; Wang, CC; Wang, SJ | 1 |
2 other study(ies) available for glutamic acid and latrepirdine
| Article | Year |
|---|---|
Latrepirdine is a potent activator of AMP-activated protein kinase and reduces neuronal excitability.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Cerebellum; Gene Silencing; Glucose Transporter Type 3; Glutamic Acid; Indoles; Membrane Potentials; Mice; Mitochondria; Neocortex; Neurons; Neuroprotective Agents; Nootropic Agents; Protein Serine-Threonine Kinases; Rats | 2013 |
Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals.
Topics: 4-Aminopyridine; Animals; Calcium; Calcium Channels, N-Type; Cerebral Cortex; Exocytosis; Glutamic Acid; Histamine Antagonists; Indoles; Male; Membrane Potentials; Neuroprotective Agents; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptosomes | 2014 |